FDA Votes in Favor of Benefit-Risk Profile for Moderna’s Flu Vaccine
Moderna said the FDA’s Vaccines and Related Biological Products Advisory Committee voted unanimously that the benefits of the vaccine, mRNA-1010, exceed the risks for the prevention of flu in adults 50 through 64 years old, and in adults 65 years of age and older.
The Source
TWSJ
Business
Opinion | Trump Explains Why He Cut a Deal With Iran
TWSJ·1h ago·3 min read
Sports
Opinion | Can ‘We the People’ Survive the AI Revolution?
TWSJ·1h ago·3 min read
World News
Air Force Buys New Generation of Drones Made to Strike Deep Into Enemy Territory
TWSJ·1h ago·3 min read
Tech
Intel Shares Surge After Trump Announces Apple Partnership
TWSJ·9h ago·3 min read
Related
On this beat
Health
How To Prioritise Your Recovery Even When Life Gets Stressful
AOHL·5h ago·3 min read
Health
Many World Cup Fans Would Rather Skip the Hydration Breaks
TNYT·7h ago·3 min read
Health
Best Vivity Lens Cataract Surgeon In Estero: Top IOL Specialist Guide
AOHL·7h ago·3 min read
Health
Utah is testing out AI doctors for prescription refills and actual doctors aren’t happy about it
TWSJ·8h ago·3 min read